Urinary Protein Reagents Market : Global Industry Analysis and Opportunity Assessment, 2032

Urinary Protein Reagents Market Outlook

The urinary protein reagents market is projected to record a CAGR of 7% during the forecast period, up from US$ 3.75 Bn in 2022 to reach a valuation of US$ 7.37 Bn by 2032.

The urinary protein reagents market is anticipated to witness promising growth opportunities during the forecast period.

Attributes	Details
Urinary Protein Reagents Market Value (2022)	US$ 3.75 Bn
Urinary Protein Reagents Market Value (2032)	US$ 7.37 Bn
Urinary Protein Reagents Market CAGR (2022-2032)	7%

Sales of urinary protein reagents is expected to rise as the prevalence of age-related disorders such as diabetes, liver, and renal disease in the senior population grows. In addition to this, demand for urinary protein reagents is rising due to rising frequency of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin, among others.

Increasing elderly population in developed and emerging countries is also projected to contribute to the growth of the urinary protein reagents market share.

Some of the key urinary protein reagents market trends promoting the demand for urinary protein reagents include rising prevalence of renal disease and urinary tract infection which further boosts demand for diagnostic testing.

What are the Key Drivers of the Urinary Protein Reagents Market Share

The demand for urinary protein reagents is predicted to rise due to the rising number of renal problems associated with advancing age and heavy alcohol intake. These factors necessitate routine urinary protein testing for observational purposes, which further boosts the sales of urinary protein reagents.

The growth of the urinary protein reagents market size is influenced by the introduction of new testing methods and the use of new technology for diagnostic testing.

The demand for urinary protein reagents is predicted to rise due to an increase in healthcare professionals' recommendations for frequent urine testing and increased awareness among the general public.

Furthermore, the sales of urinary protein reagents is predicted to increase due to rising per capita healthcare spending and healthcare parameter testing campaigns.

Some of the reasons driving the demand for urinary protein reagents include rising demand for laboratory-based diagnostic procedures and rising diagnostic healthcare budgets. As a result of these factors, the sales of urinary protein reagents are also predicted to grow during the forecast period.

The urinary protein reagents market share is also expected to develop as the prevalence of chronic disorders such as diabetes and hypertension rises. The demand for urinary protein reagents for nephrosis and urinary tract infection diagnostics is increasing rapidly.

Due to the significant number of tests performed in hospitals and diagnostic centres, hospital and diagnostic laboratories are likely to provide lucrative opportunities to the urinary protein reagents market. As a result of these factors, the sales of urinary protein reagents are anticipated to grow rapidly by 2032.

Which Region holds the Highest Growth Potential in the Urinary Protein Reagents Market

Due to the increased awareness of healthcare issues, growing demand for frequent urinary protein tests and rising sales of urinary protein reagents, North America is likely to lead the urinary protein reagents market.

As per-capita healthcare expenses, sales of urinary protein reagents and spending on early healthcare parameter diagnosis rises, Europe is predicted to generate the second-highest revenue share in urinary protein reagents.

As awareness campaigns for kidney testing grow, diagnostic testing programs expand, and the prevalence of kidney illnesses rises, the sales of urinary protein reagents in Asia Pacific is predicted to grow.

The APAC urinary protein reagents market is predicted to grow at a faster rate due to increased use of new healthcare technology and procedures in laboratory testing. Asian countries such as India and China are predicted to develop at the fastest rate throughout the projection period.

How is the Competitive Landscape in the Urinary Protein Reagents Market

Thermo Fisher Scientific, Randox Laboratories, Beckman Coulter Inc. (Danaher Corporation), Sigma-Aldrich Corporation (Merck KGaA), Bioassay Systems LLC, PerkinElmer, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Quantimetrix Corporation, Sclavo Diagnostics International Spa, Sentinel Diagnostics - Sentinel CH. S.p.A., ELITechGroup, and others are some of the key players in the urinary protein reagents market.

Recent Developments

• 77 Elektronika Kft. (Hungary) launched LabStrip U mALB/CREA urine test strips in February 2021.
• ARKRAY, Inc. (Japan) released the AutionIDaten AE-4070 small automated urine analyzer in January 2021.
• Sysmex America, Inc. announced in August 2020 that it has reached an exclusive agreement with Siemens Healthineers to distribute and service the Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use in North America.

Report Scope

Report Attribute	Details
Growth rate	CAGR of 7% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 - 2020
Forecast period	2022 - 2032
Quantitative units	Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
Segments covered	Indication, end users, region
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope	U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled	Thermo Fisher Scientific, Randox Laboratories, Beckman Coulter Inc. (Danaher Corporation), Sigma-Aldrich Corporation (Merck KGaA), Bioassay Systems LLC, PerkinElmer, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Quantimetrix Corporation, Sclavo Diagnostics International Spa, Sentinel Diagnostics - Sentinel CH. S.p.A., ELITechGrou
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.